Table 3: Prognosis factor on overall survival and progression free survival.
|
|
OS at 5 years |
p |
PFS at 5 years |
p |
|
|
CD10 |
Positive |
100% |
0.049 |
72.6% |
0.017 |
|
Negative |
72% |
|
25.3% |
|
|
|
BCL2 |
Positive |
87.5% |
0.454 |
48.4% |
0.420 |
|
Negative |
100% |
|
80% |
|
|
|
BCL6 |
Positive |
94.1% |
0.710 |
63.5% |
0.273 |
|
Negative |
83.3% |
|
45.0% |
|
|
|
MUM1 |
Positive |
76.4% |
0.089 |
58.7% |
0.465 |
|
Negative |
100% |
|
57% |
|
|
|
MUM1+/CD10- |
No |
100% |
0.002 |
65.3% |
0.006 |
|
Yes |
41.7% |
|
0% |
|
|
|
Ki67 |
≤ 60% |
100% |
0.000 |
66.7% |
0.016 |
|
> 60% |
37.5% |
|
0% |
|
|